Literature DB >> 23087368

Cryptococcus neoformans phosphoinositide-dependent kinase 1 (PDK1) ortholog is required for stress tolerance and survival in murine phagocytes.

Yeissa Chabrier-Roselló1, Kimberly J Gerik, Kristy Koselny, Louis DiDone, Jennifer K Lodge, Damian J Krysan.   

Abstract

Cryptococcus neoformans PKH2-01 and PKH2-02 are orthologous to mammalian PDK1 kinase genes. Although orthologs of these kinases have been extensively studied in S. cerevisiae, little is known about their function in pathogenic fungi. In this study, we show that PKH2-02 but not PKH2-01 is required for C. neoformans to tolerate cell wall, oxidative, nitrosative, and antifungal drug stress. Deletion of PKH2-02 leads to decreased basal levels of Pkc1 activity and, consequently, reduced activation of the cell wall integrity mitogen-activated protein kinase (MAPK) pathway in response to cell wall, oxidative, and nitrosative stress. PKH2-02 function also is required for tolerance of fluconazole and amphotericin B, two important drugs for the treatment of cryptococcosis. Furthermore, OSU-03012, an inhibitor of human PDK1, is synergistic and fungicidal in combination with fluconazole. Using a Galleria mellonella model of low-temperature cryptococcosis, we found that PKH2-02 is also required for virulence in a temperature-independent manner. Consistent with the hypersensitivity of the pkh2-02Δ mutant to oxidative and nitrosative stress, this mutant shows decreased survival in murine phagocytes compared to that of wild-type (WT) cells. In addition, we show that deletion of PKH2-02 affects the interaction between C. neoformans and phagocytes by decreasing its ability to suppress production of tumor necrosis factor alpha (TNF-α) and reactive oxygen species. Taken together, our studies demonstrate that Pkh2-02-mediated signaling in C. neoformans is crucial for stress tolerance, host-pathogen interactions, and both temperature-dependent and -independent virulence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23087368      PMCID: PMC3535849          DOI: 10.1128/EC.00235-12

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  53 in total

1.  In vitro measurement of phagocytosis and killing of Cryptococcus neoformans by macrophages.

Authors:  André Moraes Nicola; Arturo Casadevall
Journal:  Methods Mol Biol       Date:  2012

2.  Nutrients and the Pkh1/2 and Pkc1 protein kinases control mRNA decay and P-body assembly in yeast.

Authors:  Guangzuo Luo; Michael Costanzo; Charles Boone; Robert C Dickson
Journal:  J Biol Chem       Date:  2010-12-16       Impact factor: 5.157

3.  Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans.

Authors:  Hyeseung Lee; Ami Khanal Lamichhane; H Martin Garraffo; Kyung J Kwon-Chung; Yun C Chang
Journal:  Mol Microbiol       Date:  2012-03-15       Impact factor: 3.501

Review 4.  Cell wall integrity signaling in Saccharomyces cerevisiae.

Authors:  David E Levin
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

5.  Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans.

Authors:  Oliver W Liu; Cheryl D Chun; Eric D Chow; Changbin Chen; Hiten D Madhani; Suzanne M Noble
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

6.  Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes.

Authors:  A Vecchiarelli; C Retini; D Pietrella; C Monari; C Tascini; T Beccari; T R Kozel
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

7.  Loss of ypk1 function causes rapamycin sensitivity, inhibition of translation initiation and synthetic lethality in 14-3-3-deficient yeast.

Authors:  Daniel Gelperin; Lynn Horton; Anne DeChant; Jack Hensold; Sandra K Lemmon
Journal:  Genetics       Date:  2002-08       Impact factor: 4.562

8.  The cAMP/Protein Kinase A Pathway and Virulence in Cryptococcus neoformans.

Authors:  James W Kronstad; Guanggan Hu; Jaehyuk Choi
Journal:  Mycobiology       Date:  2011-09-27       Impact factor: 1.858

9.  Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.

Authors:  Tihana Bicanic; Conrad Muzoora; Annemarie E Brouwer; Graeme Meintjes; Nicky Longley; Kabanda Taseera; Kevin Rebe; Angela Loyse; Joseph Jarvis; Linda-Gail Bekker; Robin Wood; Direk Limmathurotsakul; Wirongrong Chierakul; Kasia Stepniewska; Nicholas J White; Shabbar Jaffar; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

Review 10.  Treatment of cryptococcal meningitis in resource limited settings.

Authors:  Derek J Sloan; Martin J Dedicoat; David G Lalloo
Journal:  Curr Opin Infect Dis       Date:  2009-10       Impact factor: 4.915

View more
  16 in total

1.  Uncoupling of mRNA synthesis and degradation impairs adaptation to host temperature in Cryptococcus neoformans.

Authors:  Amanda L M Bloom; J T Graham Solomons; Virginia E Havel; John C Panepinto
Journal:  Mol Microbiol       Date:  2013-06-03       Impact factor: 3.501

2.  Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge.

Authors:  Ky V Hoang; Heather Curry; Michael A Collier; Hassan Borteh; Eric M Bachelder; Larry S Schlesinger; John S Gunn; Kristy M Ainslie
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

3.  The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.

Authors:  Kristy Koselny; Julianne Green; Louis DiDone; Justin P Halterman; Annette W Fothergill; Nathan P Wiederhold; Thomas F Patterson; Melanie T Cushion; Chad Rappelye; Melanie Wellington; Damian J Krysan
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 4.  Stress signaling pathways for the pathogenicity of Cryptococcus.

Authors:  Yong-Sun Bahn; Kwang-Woo Jung
Journal:  Eukaryot Cell       Date:  2013-09-27

5.  A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis.

Authors:  Arielle Butts; Louis DiDone; Kristy Koselny; Bonnie K Baxter; Yeissa Chabrier-Rosello; Melanie Wellington; Damian J Krysan
Journal:  Eukaryot Cell       Date:  2012-12-14

6.  Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles.

Authors:  M A Collier; K J Peine; S Gautam; S Oghumu; S Varikuti; H Borteh; T L Papenfuss; A R Sataoskar; E M Bachelder; K M Ainslie
Journal:  Int J Pharm       Date:  2016-01-05       Impact factor: 5.875

7.  Opposing PKA and Hog1 signals control the post-transcriptional response to glucose availability in Cryptococcus neoformans.

Authors:  Dithi Banerjee; Amanda L M Bloom; John C Panepinto
Journal:  Mol Microbiol       Date:  2016-08-11       Impact factor: 3.501

8.  Macrophage Cryptococcus interactions: an update.

Authors:  Michael K Mansour; Jennifer L Reedy; Jenny M Tam; Jatin M Vyas
Journal:  Curr Fungal Infect Rep       Date:  2014-03-01

9.  Antitumor/Antifungal Celecoxib Derivative AR-12 is a Non-Nucleoside Inhibitor of the ANL-Family Adenylating Enzyme Acetyl CoA Synthetase.

Authors:  Kristy Koselny; Julianne Green; Lacey Favazzo; Virginia E Glazier; Louis DiDone; Shea Ransford; Damian J Krysan
Journal:  ACS Infect Dis       Date:  2016-02-23       Impact factor: 5.084

10.  High-Throughput Screen in Cryptococcus neoformans Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway Signaling.

Authors:  Kate Hartland; Jun Pu; Michelle Palmer; Sivaraman Dandapani; Philip N Moquist; Benito Munoz; Louis DiDone; Stuart L Schreiber; Damian J Krysan
Journal:  ACS Infect Dis       Date:  2015-11-06       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.